& Barrett, J
Its primary actions include: Inhibiting the reuptake of dopamine and noradrenaline in the central nervous system Minimal effect on serotonin pathways, distinguishing it from most other antidepressants Potential appetite suppression as a secondary effect, though this is not its primary indication Reducing nicotine cravings through dopaminergic pathways Bupropion is metabolised primarily in the liver by the CYP2B6 enzyme system, producing active metabolites
without DAC
Your GP or diabetes specialist will assess whether a GLP-1 receptor agonist is suitable based on NICE guidance, typically when metformin and other therapies have not achieved adequate control, or if you have a high BMI, cardiovascular disease, or chronic kidney disease
Hyperglycemia drives the accumulation of advanced glycation end products AGEs, which activate the RAGE/MAPK signaling axis, thereby inhibiting Col-II synthesis and promoting a catabolic state in chondrocytes (31)
Cellular Repair and Regeneration: Helps repair damaged cells and supports the production of new, healthy cells